文献速递传染病防控与疫情报告免疫规划

医护人员近期接种MMR疫苗与Covid-19:一项检测阴性病例对照研究

Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
PubMed 文献 · Vaccine · 2021-06-22

该研究采用检测阴性病例对照设计,利用麻疹疫情暴发期间许多医护人员接种MMR疫苗的时机,在5905名受试者中探讨MMR疫苗对SARS-CoV-2的潜在保护作用。结果显示,近期接种MMR者与未近期接种者SARS-CoV-2检测阳性的比值比为0.91(95%CI 0.76,1.09);性别分层后,男性比值比为0.43(95%CI 0.24,0.79,P=0.006),女性为1.01(95%CI 0.83,1.22,P=0.92)。结论提示MMR疫苗可能对男性有保护作用,对女性则无。

要点

  • 近期接种MMR疫苗与男性SARS-CoV-2检测阳性风险降低相关(OR 0.43)。
  • 女性中未观察到MMR疫苗对SARS-CoV-2的保护作用(OR 1.01)。
  • 总体效应无统计学显著性(OR 0.91,95%CI含1)。

核心结论

  • MMR疫苗可能对男性SARS-CoV-2感染有保护作用,对女性则无。

研究设计与样本

  • 检测阴性病例对照研究,纳入5905名受试者(男805,女5100),利用麻疹疫情中医护人员接种MMR疫苗的时机。

主要发现

  • 近期接种MMR者相比未近期接种者,SARS-CoV-2检测阳性的比值比为0.91(95%CI 0.76,1.09)。
  • 性别交互作用显著;男性比值比为0.43(95%CI 0.24,0.79,P=0.006),女性为1.01(95%CI 0.83,1.22,P=0.92)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It has been hypothesised that the measles-mumps-rubella (MMR) vaccine may afford cross-protection against SARS-CoV-2 which may contribute to the wide variability in disease severity of Covid-19. METHODS: We employed a test negative case-control study, utilising a recent measles outbreak during which many healthcare workers received the MMR vaccine, to investigate the potential protective effect of MMR against SARS-CoV-2 in 5905 subjects (n = 805 males, n = 5100 females). RESULTS: The odds ratio for testing positive for SARS-CoV-2, in recently MMR-vaccinated compared to not recently MMR-vaccinated individuals was 0.91 (95% CI 0.76, 1.09). An interaction analysis showed a significant interaction for sex. After sex-stratification, the odds ratio for testing positive for males was 0.43 (95% CI 0.24, 0.79, P = 0.006), and 1.01 (95% CI 0.83, 1.22, P = 0.92) for females. CONCLUSION: Our results indicate that there may be a protective effect of the MMR vaccine against SARS-CoV-2 in males but not females.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lundberg L, Bygdell M, Stukat von Feilitzen G, et al. Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study. Vaccine. 2021. PMID: 34187707. doi:10.1016/j.vaccine.2021.06.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。